110 related articles for article (PubMed ID: 13951293)
1. Studies of the mechanism of resistance to pyrimidines in Streptococcus faecalis. I. An unusual effect of 5-iodouracil and 5-iodo-2'-deoxyuridine.
GUNTHER HL; PRUSOFF WH
J Biol Chem; 1963 Mar; 238():1091-7. PubMed ID: 13951293
[No Abstract] [Full Text] [Related]
2. ANTI-HERPETIC ACTIVITY OF 5-IODO-2'-DEOXYURIDINE IN PRESENCE OF ITS DEGRADATION PRODUCTS.
ENGLE CG; STEWART RC
Proc Soc Exp Biol Med; 1964 Jan; 115():43-5. PubMed ID: 14117464
[No Abstract] [Full Text] [Related]
3. THE EFFECT OF NATURAL AND UNNNATURAL PYRIMIDINES AND PYRIMIDINE NUCLEOSIDES ON THE PHOSPHOROLYSIS OF 5-IODODEOXYURIDINE BY MOUSE LIVER EXTRACT.
KRISS JP; BOND SB
Biochem Pharmacol; 1964 Mar; 13():365-70. PubMed ID: 14157596
[No Abstract] [Full Text] [Related]
4. IDOXURIDINE--A PRELIMINARY REPORT.
RAVIN IJ; SIMPSON CA; ZAPPALA AF
J Pharm Sci; 1964 Aug; 53():976. PubMed ID: 14241824
[No Abstract] [Full Text] [Related]
5. A MECHANISM OF RESISTANCE TO FLUOROPYRIMIDINES.
BLOCH A; HUTCHISON DJ
Cancer Res; 1964 Apr; 24():433-9. PubMed ID: 14147816
[No Abstract] [Full Text] [Related]
6. [SIMULTANEOUS SPECTROPHOTOMETRIC DETERMINATION OF 5-IODO-2'-DEOXYURIDINE AND 5-IODOURACIL].
KAKEMI K; ARITA T; HASHI M
Yakugaku Zasshi; 1964 Oct; 84():1009-12. PubMed ID: 14250857
[No Abstract] [Full Text] [Related]
7. AN IMPROVED SYNTHESIS OF 5-IODO-2'-DEOXYURIDINE-I-131 AND 5-IODOURACIL-I-131.
BUI NM; GILLET R; DUMONT P
Int J Appl Radiat Isot; 1965 May; 16():337-9. PubMed ID: 14313715
[No Abstract] [Full Text] [Related]
8. Inhibition studies with pyrimidines on Streptococcus faecalis R.
PULESTON HS; POE CF; WITT NF
J Biol Chem; 1955 Jan; 212(1):319-23. PubMed ID: 13233233
[No Abstract] [Full Text] [Related]
9. Purification of thymidine phosphorylase from Escherichia coli and its photoinactivation in the presence of thymine, thymidine, and some halogenated analogs.
Voytek P
J Biol Chem; 1975 May; 250(10):3660-5. PubMed ID: 236298
[TBL] [Abstract][Full Text] [Related]
10. PREPARATION OF VERY HIGH SPECIFIC ACTIVITY IODODEOXYURIDINE, IODOURIDINE AND IODOURACIL, LABELLED WITH IODINE-125, -131 OR -132.
SILVESTER DJ; WHITE ND
Nature; 1963 Oct; 200():65-6. PubMed ID: 14074631
[No Abstract] [Full Text] [Related]
11. Clinical evaluation of the pyrimidine nucleosides 5-fluoro-2'-deoxyuridine and 5-iodo-2'-deoxyuridine.
PAPAC R; JACOBS E; WONG F; COLLOM A; SKOOG W; WOOD DA
Cancer Chemother Rep; 1962 Jul; 20():143-6. PubMed ID: 14483657
[No Abstract] [Full Text] [Related]
12. QUANTITATIVE E.S.R.-MEASUREMENTS OF RADIATION-INDUCED RADICALS IN NUCLEOSIDES.
MUELLER A; KOEHNLEIN W
Int J Radiat Biol Relat Stud Phys Chem Med; 1964; 8():121-30. PubMed ID: 14195521
[No Abstract] [Full Text] [Related]
13. The preparation of 5-cyanouracil and 5-cyano-2'-deoxyuridine from the corresponding 5-iodo derivative and cuprous cyanide.
Bleackley RC; Jones AS; Walker RT
Nucleic Acids Res; 1975 May; 2(5):683-90. PubMed ID: 1096081
[TBL] [Abstract][Full Text] [Related]
14. Dehalogenation of Halogenated Nucleobases and Nucleosides by Organoselenium Compounds.
Mondal S; Mugesh G
Chemistry; 2019 Feb; 25(7):1773-1780. PubMed ID: 30398293
[TBL] [Abstract][Full Text] [Related]
15. FLUORINATED PYRIMIDINES. XXIV. IN VIVO METABOLISM OF 5-TRIFLUOROMETHYLURACIL-2-C-14 AND 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE-2-C-14.
HEIDELBERGER C; BOOHAR J; KAMPSCHROER B
Cancer Res; 1965 Apr; 25():377-81. PubMed ID: 14281103
[No Abstract] [Full Text] [Related]
16. Incorporation of 5-iodouracil labelled with iodine-131 into the deoxyribonucleic acid of human leukaemic leucocytes following in vivo administration of 5-iododeoxyuridine labelled with iodine-131.
EIDINOFF ML; CHEONG L; GURPIDE EG; BENUA RS; ELLISON RR
Nature; 1959 Jun; 183(4676):1686-7. PubMed ID: 13666863
[No Abstract] [Full Text] [Related]
17. Inhibition by 6-aminothymine of the degradation of nucleosides (5-iododeoxyuridine, thymidine) and pyrimidine bases (5-iodouracil, uracil and 5-fluorouracil) in vivo.
Matthes E; Bärwolff D; Langen P
Acta Biol Med Ger; 1974; 32(5):483-502. PubMed ID: 4852467
[No Abstract] [Full Text] [Related]
18. Clinical pharmacology of 5-iodo-2'-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation.
Klecker RW; Jenkins JF; Kinsella TJ; Fine RL; Strong JM; Collins JM
Clin Pharmacol Ther; 1985 Jul; 38(1):45-51. PubMed ID: 4006375
[TBL] [Abstract][Full Text] [Related]
19. The potentiation by 5-iodo-2'-deoxyuridine (IUDR) of the tumor-inhibitory activity of 5-fluoro-2'-deoxyuridine (FUDR).
HEIDELBERGER C; GRIESBACH L; GHOBAR A
Cancer Chemother Rep; 1960 Feb; 6():37-8. PubMed ID: 14400595
[No Abstract] [Full Text] [Related]
20. Development of resistance to 2, 4-diamino-5(3'4'-dichlorphenyl)-6-methylpyrimidine (SK5265) by Streptococcus faecalis.
BURCHENAL JH; WARING GB; HUTCHISON DJ
Proc Soc Exp Biol Med; 1953 Mar; 82(3):536-8. PubMed ID: 13047456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
